Purchase Order 75N98026P00232
- Not listed
- This is a $13,459.86 firm fixed-price purchase order awarded to LGC Clinical Diagnostics Inc., a foreign-owned, for-profit manufacturer of clinical diagnostics products, by the National Institutes of Health (NIH) Clinical Center. The order is for 25-004737-SEROLOGICAL ASSAYS, with an ultimate completion date of April 14, 2025. LGC Clinical Diagnostics has previously received numerous federal contracts, primarily purchase orders, to provide a variety of diagnostic testing services, validation...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to LGC Clinical Diagnostics Inc. for $24,778.00. The contract is for the delivery of SeraCare bioservices, which include quality control tools, reference materials, controls, reagents, and biological materials to support clinical diagnostics, disease prevention, and health promotion initiatives. LGC Clinical Diagnostics, a foreign-owned, for-profit manufacturer, has been awarded...
- This federal contract award is a $14,386.50 firm fixed price purchase order issued by the National Institutes of Health (NIH) Clinical Center to LGC Clinical Diagnostics Inc., a foreign-owned, for-profit manufacturer of clinical diagnostic products. The award is for the provision of external run controls required to validate antibody/antigen viral markers on the Ortho 3600 instrument, in compliance with Food and Drug Administration (FDA) and Clinical Laboratory Improvement Amendments (CLIA)...
- This federal contract award is for the validation of the new Roche Instruments, COBAS 5800 (R) diagnostic equipment to LGC Clinical Diagnostics, Inc., a foreign-owned, for-profit manufacturer of clinical diagnostic products and reference materials. The $18,840.40 firm fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency, with an ultimate completion date of October 2, 2025. The contract does not have a set-aside designation....
- This is a $8,667.00 firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to LGC Clinical Diagnostics Inc., a foreign-owned, for-profit manufacturer of clinical diagnostics products. The contract is for the provision of SeraCare BioServices, which includes quality control tools and reference materials to support clinical laboratories, molecular diagnostics, serology testing, and other applications. LGC Clinical Diagnostics has previously...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to LGC Clinical Diagnostics Inc., a foreign-owned, for-profit manufacturer of clinical laboratory products and diagnostics. The contract, valued at $77,990.25, is for the delivery of LAB PANELS with a period of performance through September 29, 2023. LGC Clinical Diagnostics has previously provided a variety of diagnostic testing services, validation testing, laboratory panels, control...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price purchase order to LGC Clinical Diagnostics Inc. for reference materials in the amount of one thousand seven hundred eight dollars and seventy-one cents ($1,708.71). The period of performance is through September 1, 2022. No set aside designation was used for this award. LGC Clinical Diagnostics Inc. will provide the reference materials in support of COVID-19 response efforts. As a foreign owned, for-profit...
- The Defense Health Agency awarded a $47,053.56 firm fixed price purchase order to LGC Clinical Diagnostics Inc. on September 27, 2024, for calibration verification and linearity test kits for cardiac equipment and Maine standard reagents. The contract, with an ultimate completion date of March 22, 2025, carries no set-aside designation and will be performed in Italy. LGC Clinical Diagnostics Inc., a Massachusetts-based clinical diagnostics manufacturer and child entity within a larger...
- This purchase order, valued at approximately $9,094, was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases to LGC Genomics LLC. The place of performance is Beverly, Massachusetts and the period of performance is February 7, 2014 through March 12, 2014. This firm fixed price contract utilizes a purchase order vehicle to procure unspecified products or services from LGC Genomics LLC in support of...
- The National Institutes of Health Clinical Center awarded a $78,813.33 firm fixed-price purchase order to Labvantage Solutions Inc. for professional services, with an ultimate completion date of January 25, 2027. This contract, awarded on January 26, 2026, will be performed in Bethesda, Maryland, and represents a non-competitive award with no set-aside designation. Labvantage Solutions Inc., headquartered in Somerset, New Jersey, is a specialized provider of Laboratory Information Management...
The National Institutes of Health (NIH) Clinical Center awarded a firm fixed-price purchase order valued at $43,810 to LGC Clinical Diagnostics Inc., a clinical diagnostics manufacturer based in Milford, Massachusetts. The contract, awarded on April 6, 2026, with an ultimate completion date of September 30, 2026, carries no set-aside designation. LGC Clinical Diagnostics, a foreign-owned subsidiary registered in SAM.gov since 2004, specializes in manufacturing clinical diagnostic products, reference materials, and laboratory supplies for federal government agencies. The company's core competencies include developing and validating diagnostic equipment, control products, and reference materials that support medical research and clinical laboratory operations. This purchase order aligns with the NIH Clinical Center's mission to advance biomedical research and provide high-quality clinical services. LGC Clinical Diagnostics has an established track record of supporting federal health agencies, including the CDC, Defense Health Agency, and Indian Health Service, with contracts ranging from external run controls and calibration verification test kits to laboratory panels and serological assays. The firm's experience in supporting critical public health initiatives, including COVID-19 response efforts, demonstrates its capacity to deliver essential diagnostic and laboratory products to support the NIH Clinical Center's clinical operations and research objectives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.8k | 4/6/26 |